CLL Treatment: More Infections Among Real-World Patients CLL Treatment: More Infections Among Real-World Patients
A high rate of severe infections was seen in patients with chronic lymphocytic leukemia (CLL) or B-cell lymphoma who were taking ibrutinib (Imbruvica), idelalisib (Zydelig), or venetoclax (Venclexta).MDedge News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Chronic Leukemia | Chronic Lymphocytic Leukemia | Hematology | Leukemia | Lymphoma